Viewing Study NCT00464893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2026-01-22 @ 4:57 AM
Study NCT ID: NCT00464893
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 2007-04-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Sponsor: Neovii Biotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
None Gastric Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastric cancer View
None catumaxomab View
None neoadjuvant chemotherapy View
None phase II View
None interoperative View
None trifunctional antibody View